WEREWOLF THERAPEUTICS INC has a total of 26 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are SHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD, FOOTE JEFFERSON and GENSUN BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Singapore | 3 | |
#8 | Brazil | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Hicklin Daniel | 24 |
#2 | Salmeron Garcia Jose Andres | 24 |
#3 | Evnin Luke | 24 |
#4 | Bhaskar Vinay | 24 |
#5 | Winston William | 24 |
#6 | Brodkin Heather | 24 |
#7 | Baeuerle Patrick | 22 |
#8 | Seidel-Dugan Cynthia | 15 |
#9 | Wesche Holger | 12 |
#10 | Lin Shuoyen Jack | 12 |
Publication | Filing date | Title |
---|---|---|
WO2020232305A1 | Separation moieties and methods and use thereof | |
KR20210021467A | Activatable interleukin-2 polypeptide and method of use thereof | |
KR20210021468A | Activatable cytokine polypeptide and method of use thereof |